Public Employees Retirement Association of Colorado boosted its position in shares of Danaher Co. (NYSE:DHR) by 3.8% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 872,371 shares of the conglomerate’s stock after buying an additional 31,793 shares during the quarter. Danaher makes up about 0.8% of Public Employees Retirement Association of Colorado’s portfolio, making the stock its 29th largest position. Public Employees Retirement Association of Colorado’s holdings in Danaher were worth $125,997,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also recently made changes to their positions in DHR. Barings LLC grew its position in shares of Danaher by 8.7% during the 2nd quarter. Barings LLC now owns 11,922 shares of the conglomerate’s stock worth $1,703,000 after buying an additional 952 shares during the period. Capital Advisors Ltd. LLC grew its position in shares of Danaher by 527.5% during the 2nd quarter. Capital Advisors Ltd. LLC now owns 320 shares of the conglomerate’s stock worth $46,000 after buying an additional 269 shares during the period. Sullivan Bruyette Speros & Blaney LLC grew its position in shares of Danaher by 5.2% during the 2nd quarter. Sullivan Bruyette Speros & Blaney LLC now owns 14,598 shares of the conglomerate’s stock worth $2,086,000 after buying an additional 717 shares during the period. Lenox Wealth Advisors LLC grew its position in shares of Danaher by 231.3% during the 2nd quarter. Lenox Wealth Advisors LLC now owns 1,302 shares of the conglomerate’s stock worth $186,000 after buying an additional 909 shares during the period. Finally, Asahi Life Asset Management CO. LTD. acquired a new position in shares of Danaher during the 2nd quarter worth about $177,000. 78.30% of the stock is owned by hedge funds and other institutional investors.
In other news, Chairman Mitchell P. Rales purchased 2,500 shares of Danaher stock in a transaction on Friday, August 23rd. The stock was purchased at an average price of $139.52 per share, with a total value of $348,800.00. Following the transaction, the chairman now directly owns 3,030,453 shares in the company, valued at approximately $422,808,802.56. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 11.40% of the company’s stock.
Danaher (NYSE:DHR) last released its quarterly earnings results on Thursday, October 24th. The conglomerate reported $1.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.15 by $0.01. Danaher had a return on equity of 11.42% and a net margin of 12.13%. The firm had revenue of $5.04 billion during the quarter, compared to the consensus estimate of $5.02 billion. During the same quarter in the prior year, the firm posted $1.10 EPS. The business’s revenue was up 3.8% on a year-over-year basis. Equities research analysts anticipate that Danaher Co. will post 4.76 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.50%. The ex-dividend date of this dividend was Thursday, September 26th. Danaher’s dividend payout ratio (DPR) is currently 15.04%.
Several equities analysts recently issued reports on the company. Argus boosted their price objective on Danaher to $165.00 and gave the company a “buy” rating in a research report on Tuesday, July 23rd. ValuEngine lowered Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Robert W. Baird boosted their price objective on Danaher from $131.00 to $148.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Credit Suisse Group reiterated an “outperform” rating and issued a $151.00 price objective on shares of Danaher in a research report on Monday, October 14th. Finally, Wolfe Research set a $154.00 price objective on Danaher and gave the company a “buy” rating in a research report on Friday, October 25th. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $145.86.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Recommended Story: CBOE Russell 2000® Volatility Index
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.